@article{markar_sr_role_2016,
title = {Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study},
volume = {56},
issn = {0959-8049},
url = {http://www.ncbi.nlm.nih.gov/pubmed/26808298},
DOI = {10.1016/j.ejca.2015.11.024},
Language = {English},
Journal = {Eur. J. Cancer},
author = {{Markar SR} and {Gronnier C} and {Pasquer A} and {Duhamel A} and {Beal H} and {Théreaux J} and {Gagnière J} and {Lebreton G} and {Brigand C} and {Meunier B} and {Collet D} and {Mariette C}},
year = {2016},
keywords = {Adenocarcinoma/mortality, Adenocarcinoma/pathology, Adenocarcinoma/therapy*, Carcinoma, Squamous Cell/mortality, Carcinoma, Squamous Cell/pathology, Carcinoma, Squamous Cell/therapy*, Chemoradiotherapy, Adjuvant*/adverse effects, Chemoradiotherapy, Adjuvant*/mortality, Chemotherapy, Adjuvant, Chi-Square Distribution, Disease-Free Survival, Esophageal Neoplasms/mortality, Esophageal Neoplasms/pathology, Esophageal Neoplasms/therapy*, Esophagectomy*/adverse effects, Esophagectomy*/mortality, Europe, Female, Humans, Incidence, Kaplan-Meier Estimate, Logistic Models, Lymphatic Metastasis, Male, Middle Aged, Neoadjuvant Therapy*/adverse effects, Neoadjuvant Therapy*/mortality, Neoplasm Staging, Propensity Score, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome},
pages = {59-68}
}

{"_id":"NtMPXJ5FDFeG6Hqz3","bibbaseid":"markarsr-gronnierc-pasquera-duhamela-bealh-threauxj-gagnirej-lebretong-etal-roleofneoadjuvanttreatmentinclinicalt2n0m0oesophagealcancerresultsfromaretrospectivemulticentereuropeanstudy-2016","authorIDs":[],"author_short":["Markar SR","Gronnier C","Pasquer A","Duhamel A","Beal H","Théreaux J","Gagnière J","Lebreton G","Brigand C","Meunier B","Collet D","Mariette C"],"bibdata":{"bibtype":"article","type":"article","title":"Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study","volume":"56","issn":"0959-8049","url":"http://www.ncbi.nlm.nih.gov/pubmed/26808298","doi":"10.1016/j.ejca.2015.11.024","language":"English","journal":"Eur. J. Cancer","author":[{"firstnames":[],"propositions":[],"lastnames":["Markar SR"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Gronnier C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Pasquer A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Beal H"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Théreaux J"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Gagnière J"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Lebreton G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Brigand C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Meunier B"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Collet D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Mariette C"],"suffixes":[]}],"year":"2016","keywords":"Adenocarcinoma/mortality, Adenocarcinoma/pathology, Adenocarcinoma/therapy*, Carcinoma, Squamous Cell/mortality, Carcinoma, Squamous Cell/pathology, Carcinoma, Squamous Cell/therapy*, Chemoradiotherapy, Adjuvant*/adverse effects, Chemoradiotherapy, Adjuvant*/mortality, Chemotherapy, Adjuvant, Chi-Square Distribution, Disease-Free Survival, Esophageal Neoplasms/mortality, Esophageal Neoplasms/pathology, Esophageal Neoplasms/therapy*, Esophagectomy*/adverse effects, Esophagectomy*/mortality, Europe, Female, Humans, Incidence, Kaplan-Meier Estimate, Logistic Models, Lymphatic Metastasis, Male, Middle Aged, Neoadjuvant Therapy*/adverse effects, Neoadjuvant Therapy*/mortality, Neoplasm Staging, Propensity Score, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome","pages":"59-68","bibtex":"@article{markar_sr_role_2016,\r\ntitle = {Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study},\r\nvolume = {56},\r\nissn = {0959-8049},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/26808298},\r\nDOI = {10.1016/j.ejca.2015.11.024},\r\nLanguage = {English},\r\nJournal = {Eur. J. Cancer},\r\nauthor = {{Markar SR} and {Gronnier C} and {Pasquer A} and {Duhamel A} and {Beal H} and {Théreaux J} and {Gagnière J} and {Lebreton G} and {Brigand C} and {Meunier B} and {Collet D} and {Mariette C}},\r\nyear = {2016},\r\nkeywords = {Adenocarcinoma/mortality, Adenocarcinoma/pathology, Adenocarcinoma/therapy*, Carcinoma, Squamous Cell/mortality, Carcinoma, Squamous Cell/pathology, Carcinoma, Squamous Cell/therapy*, Chemoradiotherapy, Adjuvant*/adverse effects, Chemoradiotherapy, Adjuvant*/mortality, Chemotherapy, Adjuvant, Chi-Square Distribution, Disease-Free Survival, Esophageal Neoplasms/mortality, Esophageal Neoplasms/pathology, Esophageal Neoplasms/therapy*, Esophagectomy*/adverse effects, Esophagectomy*/mortality, Europe, Female, Humans, Incidence, Kaplan-Meier Estimate, Logistic Models, Lymphatic Metastasis, Male, Middle Aged, Neoadjuvant Therapy*/adverse effects, Neoadjuvant Therapy*/mortality, Neoplasm Staging, Propensity Score, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome},\r\npages = {59-68}\r\n}\r\n\r\n","author_short":["Markar SR","Gronnier C","Pasquer A","Duhamel A","Beal H","Théreaux J","Gagnière J","Lebreton G","Brigand C","Meunier B","Collet D","Mariette C"],"key":"markar_sr_role_2016","id":"markar_sr_role_2016","bibbaseid":"markarsr-gronnierc-pasquera-duhamela-bealh-threauxj-gagnirej-lebretong-etal-roleofneoadjuvanttreatmentinclinicalt2n0m0oesophagealcancerresultsfromaretrospectivemulticentereuropeanstudy-2016","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/26808298"},"keyword":["Adenocarcinoma/mortality","Adenocarcinoma/pathology","Adenocarcinoma/therapy*","Carcinoma","Squamous Cell/mortality","Carcinoma","Squamous Cell/pathology","Carcinoma","Squamous Cell/therapy*","Chemoradiotherapy","Adjuvant*/adverse effects","Chemoradiotherapy","Adjuvant*/mortality","Chemotherapy","Adjuvant","Chi-Square Distribution","Disease-Free Survival","Esophageal Neoplasms/mortality","Esophageal Neoplasms/pathology","Esophageal Neoplasms/therapy*","Esophagectomy*/adverse effects","Esophagectomy*/mortality","Europe","Female","Humans","Incidence","Kaplan-Meier Estimate","Logistic Models","Lymphatic Metastasis","Male","Middle Aged","Neoadjuvant Therapy*/adverse effects","Neoadjuvant Therapy*/mortality","Neoplasm Staging","Propensity Score","Retrospective Studies","Risk Factors","Time Factors","Treatment Outcome"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:54.941Z","downloads":0,"keywords":["adenocarcinoma/mortality","adenocarcinoma/pathology","adenocarcinoma/therapy*","carcinoma","squamous cell/mortality","carcinoma","squamous cell/pathology","carcinoma","squamous cell/therapy*","chemoradiotherapy","adjuvant*/adverse effects","chemoradiotherapy","adjuvant*/mortality","chemotherapy","adjuvant","chi-square distribution","disease-free survival","esophageal neoplasms/mortality","esophageal neoplasms/pathology","esophageal neoplasms/therapy*","esophagectomy*/adverse effects","esophagectomy*/mortality","europe","female","humans","incidence","kaplan-meier estimate","logistic models","lymphatic metastasis","male","middle aged","neoadjuvant therapy*/adverse effects","neoadjuvant therapy*/mortality","neoplasm staging","propensity score","retrospective studies","risk factors","time factors","treatment outcome"],"search_terms":["role","neoadjuvant","treatment","clinical","t2n0m0","oesophageal","cancer","results","retrospective","multi","center","european","study","markar sr","gronnier c","pasquer a","duhamel a","beal h","théreaux j","gagnière j","lebreton g","brigand c","meunier b","collet d","mariette c"],"title":"Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study","year":2016,"dataSources":["Tt6zYqvN5kE3wbwiR"]}